Sciensus's Gamunex homecare contract with Belfast HSC Trust ended early
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 7 July 2026 to 30 June 2028
Belfast Health and Social Care Trust bought Gamunex 10% immunoglobulin from Sciensus Pharma Services for patients treated through a homecare service. The contract covered supply and delivery of the injection, which is given by infusion.
The trust awarded the £400,000 contract directly in June 2026, to run for two years. It ended early, in September 2026, and no reason was published.
Contract ends June 2028
- What
- Homecare medicines services
- Supplier
- Sciensus Pharma Services Limited
- Value
- £400,000
- How it was bought
- Direct award
- Dates and next
- Jul 2026 to Jun 2028